| Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15 H Zdimerova, A Murer, C Engelmann, A Raykova, Y Deng, C Gujer, ... European journal of immunology 51 (1), 64-75, 2021 | 85 | 2021 |
| Vaccination against the Epstein–Barr virus J Rühl, CS Leung, C Münz Cellular and Molecular Life Sciences 77, 4315-4324, 2020 | 69 | 2020 |
| MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo A Murer, J Rühl, A Zbinden, R Capaul, W Hammerschmidt, O Chijioke, ... MBio 10 (1), 10.1128/mbio. 01941-18, 2019 | 64 | 2019 |
| Aberrant Lck signal via CD28 costimulation augments antigen-specific functionality and tumor control by redirected T cells with PD-1 blockade in humanized mice P Gulati, J Rühl, A Kannan, M Pircher, P Schuberth, KJ Nytko, M Pruschy, ... Clinical Cancer Research 24 (16), 3981-3993, 2018 | 63 | 2018 |
| Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas J Rühl, C Citterio, C Engelmann, T Haigh, A Dzionek, J Dreyer, R Khanna, ... The Journal of clinical investigation 129 (5), 2071-2087, 2019 | 59 | 2019 |
| EBV renders B cells susceptible to HIV-1 in humanized mice D McHugh, R Myburgh, N Caduff, M Spohn, YL Kok, CW Keller, A Murer, ... Life science alliance 3 (8), 2020 | 32 | 2020 |
| Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C‐type lectin receptor Langerin L Bellmann, H Strandt, C Zelle‐Rieser, D Ortner, CH Tripp, S Schmid, ... European Journal of Immunology 52 (11), 1829-1841, 2022 | 9 | 2022 |
| KSHV infection of B cells primes protective T cell responses in humanized mice N Caduff, L Rieble, M Böni, D McHugh, R Roshan, W Miley, N Labo, ... Nature Communications 15 (1), 4841, 2024 | 1 | 2024 |
| Chikungunya virus envelope protein E2 provides a vector for targeted antigen delivery to human dermal CD14+ dendritic cells A Brulefert, M Kraemer, M Cumin, A Selle, A Hoste, HH Gad, J Rühl, ... Journal of Investigative Dermatology 141 (12), 2985-2989. e5, 2021 | 1 | 2021 |
| HLA-DR15+ Donors Reconstitute Hyperactive T Cells in Humanized Mice with Defective EBV-Specific Immune Control H Zdimerova, C Engelmann, J Rühl, B Chatterjee, C Münz ACTRIMS Forum 2019, 2019 | | 2019 |
| Erratum for Murer et al.,“MicroRNAs of Epstein-Barr virus attenuate T-cell-mediated immune control in vivo.” mBio 10: e01482-19 A Murer, J Rühl, A Zbinden, R Capaul, W Hammerschmidt, O Chijioke, ... | | 2019 |
| Development of an Active EBV Vaccination Strategy Based on EBNA1-Specific T-Cell Immunity J Rühl University of Zurich, 2018 | | 2018 |
| Eliciting protective T cell immunity against EBV-associated malignancies by vaccination J Rühl, C Citterio, C Leung, C Münz European Journal of Cancer 92, S19, 2018 | | 2018 |
| Intradermal injection of antigen: Antibody fusion proteins directed against lectin receptors targets defined dendritic cell subsets in human skin and elicits T cell responses L Bellmann, S Schaffenrath, B del Frari, K Komenda, G Djedovic, J Rühl, ... Journal of Investigative Dermatology 136 (9), S234-S234, 2016 | | 2016 |
